Cargando…
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
Immune checkpoint inhibitors (ICIs) are promising agents for treating melanoma. Given that autoimmune skin diseases exhibit hyper immune reaction, investigation of immune cells from autoimmune skin disease is crucial to validate the effectiveness of ICIs in melanoma treatment. We employed multipanel...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497583/ https://www.ncbi.nlm.nih.gov/pubmed/37700026 http://dx.doi.org/10.1038/s41598-023-42238-3 |